← Eichor
Condition: Transformation Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Transformation

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

MPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People With Myel
Phase N/A · 2 location(s) · MPN Research Foundation · NCT07362225Research on Early Diagnosis and Clinical Transformation of Nuclide Probe Based on Bioorthogonal-gastric Cancer Mucin Tar
NA · 1 location(s) · Hua Zhu · NCT06429891Integrated Molecular and Clinical Profiling of Transformed Splenic Marginal Zone Lymphoma
Phase N/A · 7 location(s) · International Extranodal Lymphoma Study Group (IELSG) · NCT06712459Establishment and Clinical Transformation of ADC Drug Efficacy Evaluation System for Breast Cancer Based on Molecular Im
NA · 1 location(s) · Peking University Cancer Hospital & Institute · NCT06715020Epcoritamab Compared to Observation for Treating B-cell Lymphoma Patients Not in Complete Remission After CD19-directed
Phase 2 · 6 location(s) · Academic and Community Cancer Research United · NCT06238648Scientific Validity Assessment and Optimization of AI-Generated A3/A4 Type Questions for the Chinese Medical Licensing E
Phase N/A · 1 location(s) · Guangdong Provincial People's Hospital · NCT07505862Housing, Environment, And Living Conditions for Transformed Health
NA · 1 location(s) · University of Alabama at Birmingham · NCT06925373Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-
Phase 1 · 8 location(s) · Newave Pharmaceutical Inc · NCT04771572One-4-ALL Initiative
NA · 1 location(s) · University of Colorado, Denver · NCT05454969Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Underg
Phase 1 · 1 location(s) · M.D. Anderson Cancer Center · NCT03630991PRESERVE & CONNECT: Impact Study of the BPC
NA · 2 location(s) · University of Vermont · NCT06160050Efficacy and Safety of Variceal Embolization Combined With Partial Splenic Artery Embolization for Variceal Bleeding in
NA · 1 location(s) · Air Force Military Medical University, China · NCT07310316Strengthening Relationships and Mental Health Through a Couples-Based Economic Empowerment Intervention
NA · 2 location(s) · Technical University of Munich · NCT07108049ONO-4538 Study in Patients With Richter's Transformation
Phase 2 · 10 location(s) · Ono Pharmaceutical Co., Ltd. · NCT06936943Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma
Phase 1 · 7 location(s) · AIDS Malignancy Consortium · NCT05077527Loncastuximab Tesirine and Mosunetuzumab for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Phase 2 · 1 location(s) · City of Hope Medical Center · NCT05672251Efficacy and Safety of Zanubrutinib Plus Tislelizumab Treatment with or Without Sonrotoclax for Patients with Richter Tr
Phase 2 · 11 location(s) · German CLL Study Group · NCT04271956Single Arm, Prospective, Multicenter Clinical Study of TACE With Adebrelimab and Bevacizumab for Unresectable Hepatocell
Phase 2 · 1 location(s) · The First Affiliated Hospital of Xiamen University · NCT05970666Zanubrutinib and Lisocabtagene Maraleucel for the Treatment of Richter's Syndrome
Phase 2 · 3 location(s) · Aseel Alsouqi · NCT05873712Comparison of LLETZ Versus LEEP for the Treatment of Cervical Dysplasia
NA · 1 location(s) · Ruhr University of Bochum · NCT04772937Clinical Trial for Safety and Effectiveness Evaluation of Tarlatamab (AMG757) With Etoposide, Carboplatin and Atezolizum
Phase 2 · 1 location(s) · Se-Hoon Lee · NCT06830694Salivary Biomarkers in Periodontal Disease Progression
Phase N/A · 1 location(s) · Suleyman Demirel University · NCT07661784Phase I Study of Allogeneic Transforming Growth Factor-beta Receptor Type 2 Knockout CD70 CAR NK Cells in Treatment Refr
Phase 1 · 1 location(s) · M.D. Anderson Cancer Center · NCT07072234Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult
Phase 2 · 12 location(s) · Pfizer · NCT07476287Transforming Ovarian Cancer Diagnostic Pathways
Phase N/A · 3 location(s) · Professor Sudha Sundar · NCT06129968Autologous Stem Cell Transplant Followed by Polatuzumab Vedotin in Patients With B-cell Non-Hodgkin and Hodgkin Lymphoma
Phase 1/Phase 2 · 1 location(s) · New York Medical College · NCT04491370Harlem Strong Mental Health Coalition
NA · 2 location(s) · City University of New York, School of Public Health · NCT05833555Time-limited Triplet Combination of Pirtobrutinib, Venetoclax, and Obinutuzumab for Patients With Treatment-naïve Chroni
Phase 2 · 1 location(s) · M.D. Anderson Cancer Center · NCT05536349Comparison of Transforming Powder Dressing to NPIAP Recommended Standard of Care Therapies in Stage 2, 3 and 4 Pressure
NA · 14 location(s) · ULURU Inc. · NCT05496296Indian Transforming Alzheimer's Care Training (INTACT)
NA · 1 location(s) · Washington State University · NCT06397339
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.